The oral route presents a major barrier to macromolecular drugs, whose oral bioavailability is invariably well below the therapeutic level.Especially for proteins and peptides because of their gastric instabihty, susceptibility to enzymatic degradation in the gastrointestinal tract, and low permeability across the intestinal epithelium.